Hot Penny Stocks To Watch Right Now

DuPont (DD) slipped on Thursday after its first quarter missed analysts��estimates.

The conglomerate said it earned $1.44 billion or $1.54 a share; excluding one-time items, per-share earnings were $1.58 a share, up two cents from the year-ago period but a penny below the $1.59 consensus.

Revenue slipped 2.7% to $10.1 billion, also below the $10.45 analysts were expecting.

The company noted that the extraordinarily harsh winter in many parts of the country hurt the results, to the tune of seven cents a share, as farmers delayed buying seeds and other agricultural products. Political uncertainty also disrupted sales in Ukraine, one of the world�� largest corn and wheat exporters.

S&P Capital IQ�� Christopher Muir was downbeat about the prospect of DuPont�� outlook improving in the near term, lowering his rating on the stock to Sell from Hold, and lowered his target price by $1 to $64. ��e negatively view the 3.4% year-over-year drop in sales, though the drop was more than offset by strong cost control efforts. Q1 recurring EPS of $1.58, vs. $1.56, missed our $1.76 estimate and the $1.59 Capital IQ consensus. The shares are yielding 2.7%.

Hot Oil Stocks To Buy For 2015: (NWBO)

Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in the discovery, development, and commercialization of immunotherapy products that generate and enhance immune system responses to treat cancer in the United States. Its technology platforms comprise dendritic cell-based cancer vaccines (DCVax) and monoclonal antibodies for cancer therapeutics. The company?s product candidates include DCVax-Prostate for the treatment of non-metastatic hormone independent prostate cancer, which cleared Phase III clinical trial; DCVax-Brain that is in Phase II clinical trial for the treatment of glioblastoma multiforme; and DCVax-LB, which cleared Phase I clinical trial for the treatment of non-small cell lung cancer. Its product candidates also comprise DCVax-Direct that cleared Phase I clinical trial for the treatment of ovarian, head, and neck cancer; and DCVax-L, which completed Phase I/II clinical trials for the treatment of resectable solid tumors. In addition, the company develops CXCR4 antibodies, which are involved in various phases of disease progression, including proliferation of the primary tumor, migration of cancer cells out of the primary tumor, and establishment of distant metastatic sites for the treatment of non-small cell lung cancer, breast cancer, glioblastoma multiforme, colon cancer, melanoma, prostate, pancreatic, kidney, ovarian, and certain blood cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Advisors' Opinion:

• [By Smith On Stocks]

  Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.

Hot Penny Stocks To Watch Right Now: Nuveen Preferred and Convertible Income Fund (JPC)

Nuveen Multi-Strategy Income & Growth Fund is a close-ended balanced mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Asset Management, Spectrum Asset Management, Tradewinds Global Investors, LLC, and Symphony Asset Management, LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in the stocks of companies operating across diversified sectors. For the fixed income portfolio, it invests in the debt instruments, including high yield debt and senior loans. The fund benchmarks the performance of its portfolio against the Merrill Lynch Preferred Stock Hybrid Securities Index, Lehman Tier 1 Capital Securities Index, Merrill Lynch All U.S. Convertibles Index, and CSFB High Yield index. It was formerly known as Nuveen Preferred and Convertible Income Fund. Nuveen Multi-Strategy Income & Growth Fund was formed on March 26, 2003 and is domiciled in the United States.

Advisors' Opinion:

• [By Douglas A. McIntyre]

  J.C. Penney (NYSE: JPC) and the KMart and Sears divisions of Sears Holdings (NASDAQ: SHLD) are supposes to be the losers among large U.S. retailers. Their stores are too old, their brands too badly damaged, and their balance sheet too frail for either to do well in the white hot competition for holiday sales. However, their stock prices say otherwise, which means there is some expectation that they will outperform forecasts.

Hot Penny Stocks To Watch Right Now: Tenet Healthcare Corporation(THC)

Tenet Healthcare Corporation, an investor-owned health care services company, operates acute care hospitals and related health care facilities. The company?s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive care, critical care and/or coronary care units, physical therapy; and orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, liver, kidney, and bone marrow transplants for children; gamma-knife brain surgery; and cyberknife surgery for tumors and lesions in the brain, lung, neck, and spine. As of June 30, 2011, it operated 49 acute care hospitals, and a critical access hospital with a combined total of 13,420 licensed beds primarily serving urban and suburban communities in 11 states of the United State s. The company also owns an interest in a health maintenance organization and operate various related health care facilities, including a long-term acute care hospital and various medical office buildings; revenue cycle management and patient communications services businesses; physician practices; captive insurance companies; and other ancillary health care businesses, such as including ambulatory surgery centers, diagnostic imaging centers, and occupational and rural health care clinics. In addition, Tenet Healthcare Corporation owns an interest in a management services subsidiary that provides network development, utilization management, claims processing, and contract negotiation services to physician organizations and hospitals that assume managed care risk. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Advisors' Opinion:

• [By Keith Speights]

  Medicare beneficiaries
  Some investors benefited greatly from the proposed Medicare reimbursement increase. Shares of Tenet Healthcare (NYSE: THC  ) surged nearly 7%. Tenet's market cap, in turn, rose around $290 million.

• [By Sue Chang]

  Tenet Healthcare Corp. (THC) �is likely to post earnings of 46 cents a share in the third quarter. The health-care services company recently completed its purchase of Vanguard Health Systems Inc. for about $4.3 billion.

• [By Sean Williams]

  1. Hospitals are cutting back on capital expenditures.
  The hospital sector has been revered as the biggest winner of all under the new health care reform -- and it's not hard to understand why. The two largest hospital operators in the U.S., HCA Holdings (NYSE: HCA  ) and Tenet Healthcare (NYSE: THC  ) , both lost a significant sum of their revenue to doubtful accounts last year by treating patients who were unable to pay their bill. For HCA, this figure totaled close to $3.8 billion, while it was a more subdued $785 million for Tenet. The individual mandate portion of the PPACA, which requires everyone to carry health insurance, should go a long way to eliminating a good chunk of this doubtful provision.

• [By Seth Jayson]

  Tenet Healthcare (NYSE: THC  ) reported earnings on April 30. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Tenet Healthcare missed slightly on revenues and beat expectations on earnings per share.

Hot Penny Stocks To Watch Right Now: Amsurg Corp.(AMSG)

AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. The company?s surgery centers perform colonoscopy and other endoscopy procedures in the area of gastroenterology; cataracts and retinal laser surgery in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. As of December 31, 2010, it owned interest in 204 surgery centers in 33 states and the District of Columbia, including 140 centers performed gastrointestinal endoscopy procedures, 37 centers performed ophthalmology surgery procedures, 19 centers were multiple specialties, and 8 centers performed orthopaedic procedures. AmSurg Corp. markets its surgery centers directly to patients; and referring physicians and third-party payors, such as health maintenance organizations, preferred provider organizations, other managed care o rganizations, and employers. The company was founded in 1992 and is headquartered in Nashville, Tennessee.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of AmSurg (NASDAQ: AMSG) were 2.07 percent to $44.85 after the company priced 8.5 million share offering at $45.00 per share. Baird upgraded Amsurg from Neutral to Outperform and raised the price target from $44.00 to $55.00.